Project Grant R43DE033567

Award Date 8/7/24
Completion Date 8/6/25
Dollars Obligated $409K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Pasadena, CA 91107, USA
Similar Awards
This $162,216 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports the ADA Forsyth Institute's research to investigate microbe-microbe interactions within the oral microbiome. The study aims to employ a combination of expansion microscopy and multiplex FISH imaging to analyze microbial organization and quantify adhesion forces at the single-cell level. This approach...
This $656,315 Project Grant was awarded on September 1, 2024 by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121). The overarching goal is to mechanistically study the effect of biomaterial cyclic strain on the pathogenesis of oral microbes, including the fungal strain Candida albicans and denture-related microbiota. The research aims to understand how chewing actions may fuel the progression of...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $205,000.00 to The Regents of the University of California, San Francisco (UCSF) to investigate the relationship between the oral microbiome and adverse outcomes in pediatric hematopoietic cell transplant recipients. The research aims to determine how dental caries and the cariogenic oral microbiome prior to...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $226,500 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Medical University of South Carolina. The goal of this 2-year research project is to define how oral pathogens affect aging-associated immune responses and determine if inhibition of the CD38 enzyme can alleviate inflammatory bone loss and aging-associated immune responses induced by oral bacteria. The researchers will...
The Project Grant award R03DE034037, funded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), will support a $170,746 longitudinal study to investigate the relationship between changes in the oral microbiome and the development of oral mucositis and bloodstream infections in children undergoing hematopoietic cell transplants. The Research Institute at Nationwide Children's Hospital, a prominent non-profit...
This $470,279 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) will support research to characterize the role of bacterial oxidative stress responses in the ecology and pathogenicity of oral Streptococcus species. The key objectives of this 5-year project are to: 1) identify and examine the impact of genes and pathways that allow oral Streptococcus species to respond to the...
This Project Grant award of $155,500.00 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program. The award will support a comprehensive research project at the University of Iowa to determine the contributions of the oral virome, or the diverse viral community inhabiting the oral cavity, to oral health and disease. The research will leverage extensive publicly available metagenomic and...
This federal Project Grant award, funded by the National Institute of Dental and Craniofacial Research (NIDCR), aims to provide causal evidence on the relationship between poor oral health and heart disease. The $331,999 award under the CFDA 93.121 Oral Diseases and Disorders Research program will support a research project at Lehigh University that will leverage computational genomics methods and longitudinal data from the Health and Retirement Study. The key objectives are to determine the...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), provides $550,296.00 to develop a multimodal imaging-based diagnostic system for assessing the risk of precancerous oral lesions. The key products and services to be delivered under this award include: Development of machine learning and deep learning models using Fourier transform infrared (FTIR) imaging...
The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), has awarded a $306,499 Project Grant to Oridivus LLC located in Decatur, Georgia. The grant, titled "Innovative Oral Regenerative Therapy Leveraging Immunoregenerative Mechanisms," aims to develop an immunoregenerative approach to improve oral wound healing. Specifically, the project will compare the efficacy of FTY720 nanofibers versus...

The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), awarded a $409,403 Project Grant to Branchpoint Biosciences Inc. to develop a comprehensive qPCR-based oral microbiome profiling platform. The goal is to create a cost-effective research tool that can accurately screen the oral microbiome without the limitations of next-generation sequencing techniques. The Phase 1 award will fund the following objectives: (1) determine oral panel targets by analyzing public metagenomic data to identify abundant and prevalent oral microbes, and (2) design and validate qPCR assays targeting these identified microbes. Successful completion of this Phase 1 project will establish a validated qPCR panel capable of quantifying the bacteria and archaea commonly found in the human oral cavity, which can then be further evaluated in a future Phase 2 proposal.

Generated 5/13/25, 3:32 AM